Listeriosis Market to Reach USD 670 Million by 2034

Listeriosis is a serious infection caused by Listeria monocytogenes, a foodborne pathogen associated with contaminated dairy, meat, seafood, and ready-to-eat products. Although relatively rare, listeriosis has high morbidity and mortality, particularly among pregnant women, newborns, elderly individuals, and immunocompromised patients. Outbreaks can have devastating public health consequences and lead to major recalls across the food industry.
The global listeriosis market is expanding due to increasing foodborne illness surveillance, rising awareness of food safety, and advances in rapid diagnostics, antimicrobial therapies, and food testing technologies. Public health agencies and regulatory bodies worldwide are prioritizing listeriosis management, fueling investment in research and preventive measures.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71748

Market Overview
The global Listeriosis market was valued at USD 320 million in 2024 and is projected to reach USD 670 million by 2034, growing at a CAGR of 7.6% during the forecast period.

Key Highlights
Market Size 2024: Estimated at USD 320 million
Forecast 2034: Expected to reach USD 670 million
CAGR (2025-2034): 7.6%

Market Drivers
Rising incidence of foodborne infections globally.
Growing adoption of rapid diagnostic tools in clinical and food safety labs.
Increasing regulatory focus on food safety and outbreak prevention.
Advances in antimicrobial therapies and supportive care for high-risk patients.

Market Challenges
Low awareness of listeriosis in developing regions.
Limited treatment options beyond standard antibiotics (ampicillin, gentamicin).
High costs of advanced diagnostic tools.

Leading Players
Key companies in the listeriosis market include bioMérieux, Thermo Fisher Scientific, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Pfizer Inc., Merck & Co., Danaher Corporation, Neogen Corporation, Hardy Diagnostics, and Illumina Inc.

Segmentation Analysis
By Product
Diagnostic Kits (PCR, ELISA, Rapid Immunoassays)
Antibiotics (Ampicillin, Gentamicin, Trimethoprim-Sulfamethoxazole)
Food Testing Solutions
Adjunctive & Supportive Therapies

By Technology
Molecular Diagnostics (PCR, qPCR, NGS)
Immunoassay-Based Testing
Culture Methods
Point-of-Care Diagnostics

By End Use
Hospitals
Diagnostic Laboratories
Food Safety Testing Centers
Research Institutes

By Application
Pregnancy-Associated Listeriosis
Neonatal Listeriosis
Immunocompromised & Elderly Patients
Foodborne Outbreak Management

Summary:
The market is dominated by diagnostics and antibiotics, but the fastest-growing segment is food safety testing solutions, driven by stricter regulations and consumer demand for safe products. Hospitals and diagnostic labs remain the largest end users.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/71748/listeriosis-market

Regional Analysis
North America
Largest market due to advanced diagnostic systems, strong food safety regulations, and frequent outbreak surveillance. The U.S. leads with active CDC programs and widespread testing adoption.
Europe
Significant market share, supported by stringent European Food Safety Authority (EFSA) regulations and robust foodborne illness reporting systems. Germany, the UK, and France are major contributors.
Asia-Pacific
Expected to post the fastest CAGR due to rising foodborne infection rates, increasing healthcare awareness, and expanding adoption of molecular diagnostics in China, India, and Japan.
Middle East & Africa
Smaller market but growing gradually due to improving food safety regulations and awareness campaigns.
Latin America
Emerging opportunities in Brazil, Mexico, and Argentina, supported by growing food exports and stronger public health policies.

Regional Summary:
North America and Europe dominate revenues, while Asia-Pacific is projected to grow the fastest, supported by high population exposure to foodborne pathogens and expanding food safety infrastructure.

Market Dynamics
Key Growth Drivers
Increasing foodborne illness outbreaks worldwide.
Expanding adoption of molecular diagnostics for faster results.
Rising government initiatives to strengthen food safety surveillance.
Growing awareness of vulnerable populations, particularly pregnant women and newborns.

Key Challenges
Limited availability of effective therapeutic options.
Lack of awareness and underreporting in developing countries.
Cost barriers for advanced testing methods in low-income regions.

Latest Market Trends
Expansion of next-generation sequencing (NGS) in outbreak tracing.
Development of portable diagnostic kits for point-of-care testing.
Growth of AI-driven food safety monitoring systems.
Increasing collaboration between food manufacturers and diagnostic companies.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71748

Competitor Analysis
Major Players
bioMérieux - Leading provider of diagnostic kits for foodborne pathogens.
Thermo Fisher Scientific - Strong portfolio in PCR and NGS-based solutions.
Abbott Laboratories - Active in rapid immunoassay diagnostics.
F. Hoffmann-La Roche Ltd. - Focused on molecular diagnostic platforms.
Pfizer Inc. & Merck & Co. - Leading antibiotic providers for clinical treatment.
Danaher Corporation & Neogen Corporation - Major players in food safety testing.
Hardy Diagnostics - Specialized in microbiology testing products.
Illumina Inc. - Key provider of sequencing technologies for outbreak tracing.

Competitive Landscape Summary:
The listeriosis market is diagnostics-driven, with companies like bioMérieux, Thermo Fisher, and Roche leading in lab testing solutions. Pharmaceutical companies provide standard antibiotics, while Illumina and Neogen drive innovation in sequencing and food safety platforms.

Conclusion
The Listeriosis market is projected to grow from USD 320 million in 2024 to USD 670 million by 2034, at a CAGR of 7.6%. The rise in foodborne infections, growing adoption of rapid diagnostics, and stricter food safety regulations are fueling this growth.
Although challenges remain - particularly underdiagnosis, limited treatment options, and access barriers - the outlook is positive as global food safety standards strengthen and diagnostic innovations accelerate.

This report is also available in the following languages : Japanese (リステリア症市場), Korean (리스테리아증 시장), Chinese (李斯特菌病市场), French (Marché de la listériose), German (Listeriose-Markt), and Italian (Mercato della listeriosi), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71748

Our More Reports:
Sustainable Refrigeration Technology Market
https://exactitudeconsultancy.com/reports/72368/sustainable-refrigeration-technology-market

Astaxanthin Market
https://exactitudeconsultancy.com/reports/72369/astaxanthin-market

Epigenomics Market
https://exactitudeconsultancy.com/reports/72370/epigenomics-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.